65 related articles for article (PubMed ID: 1671333)
1. Functional antagonism between hormone receptor systems: modulation of glycoprotein secretion in secretory epithelial cells.
Amin DN; Goswami S; Klein T; Maayani S; Marom Z
Am J Respir Cell Mol Biol; 1991 Feb; 4(2):135-9. PubMed ID: 1671333
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
4. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
[TBL] [Abstract][Full Text] [Related]
5. Additive effect of VIP or isoproterenol on forskolin-stimulated cyclic AMP accumulation in rat prostatic epithelial cells.
Carmena MJ; Sancho JI; Prieto JC
Biochem Int; 1986 Sep; 13(3):479-85. PubMed ID: 3024642
[TBL] [Abstract][Full Text] [Related]
6. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
Dérand R; Montoni A; Bulteau-Pignoux L; Janet T; Moreau B; Muller JM; Becq F
Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
[TBL] [Abstract][Full Text] [Related]
7. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
Hirota A; Kiuchi Y; Nii H; Gregory DS
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic cholinergic inhibition of adenylate cyclase in the rabbit iris-ciliary body and ciliary epithelium.
Jumblatt JE; North GT; Hackmiller RC
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1103-8. PubMed ID: 2162335
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell line.
Olasmaa M; Påhlman S; Terenius L
Neurosci Lett; 1987 Dec; 83(1-2):161-6. PubMed ID: 2831476
[TBL] [Abstract][Full Text] [Related]
10. Src-kinase-dependent epidermal growth factor receptor transactivation in salivary mucin secretion in response to beta-adrenergic G-protein-coupled receptor activation.
Slomiany BL; Slomiany A
Inflammopharmacology; 2004; 12(3):233-45. PubMed ID: 15527548
[TBL] [Abstract][Full Text] [Related]
11. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
[TBL] [Abstract][Full Text] [Related]
12. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells.
Carmena MJ; Hueso C; Guijarro LG; Prieto JC
Regul Pept; 1991 May; 33(3):287-97. PubMed ID: 1652781
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of vasoactive intestinal peptide receptors by protein kinase C in fetal human non-pigmented ciliary epithelial cells.
Crook RB; Yabu JM
Exp Eye Res; 1994 Jul; 59(1):31-9. PubMed ID: 7835396
[TBL] [Abstract][Full Text] [Related]
18. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
Meneray MA; Fields TY; Bennett DJ
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP response to vasoactive intestinal peptide and beta-adrenergic or cholinergic agonists in isolated epithelial cells of rat ventral prostate.
Carmena MJ; Prieto JC
Biosci Rep; 1985 Sep; 5(9):791-7. PubMed ID: 3002512
[TBL] [Abstract][Full Text] [Related]
20. Interaction between catecholamines and vasoactive intestinal peptide in cultured astrocytes.
Hansson E; Rönnbäck L
Neuropharmacology; 1988 Mar; 27(3):295-300. PubMed ID: 2836754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
